Literature DB >> 32880615

Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions.

Matthijs Kox1, Nicole J B Waalders1, Emma J Kooistra1, Jelle Gerretsen1, Peter Pickkers1.   

Abstract

Entities:  

Year:  2020        PMID： 32880615      PMCID： PMC7489366          DOI： 10.1001/jama.2020.17052

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers.

Authors:  Sameena S Khan; Meghan S Smith; Debra Reda; Anthony F Suffredini; J Philip McCoy
Journal:  Cytometry B Clin Cytom       Date:  2004-09       Impact factor: 3.058

Review 2.  Into the eye of the cytokine storm.

Authors:  Jennifer R Tisoncik; Marcus J Korth; Cameron P Simmons; Jeremy Farrar; Thomas R Martin; Michael G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2012-03       Impact factor: 11.056

3.  Is a "Cytokine Storm" Relevant to COVID-19?

Authors:  Pratik Sinha; Michael A Matthay; Carolyn S Calfee
Journal:  JAMA Intern Med       Date:  2020-09-01       Impact factor: 21.873

4.  Norepinephrine Contributes to Enterocyte Damage in Septic Shock Patients: A Prospective Cohort Study.

Authors:  Quirine L M Habes; Lisa van Ede; Jelle Gerretsen; Matthijs Kox; Peter Pickkers
Journal:  Shock       Date:  2018-02       Impact factor: 3.454

5.  The Involvement of Danger-Associated Molecular Patterns in the Development of Immunoparalysis in Cardiac Arrest Patients.

Authors:  Kim Timmermans; Matthijs Kox; Jelle Gerretsen; Esther Peters; Gert Jan Scheffer; Johannes G van der Hoeven; Peter Pickkers; Cornelia W Hoedemaekers
Journal:  Crit Care Med       Date:  2015-11       Impact factor: 7.598

6.  Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients.

Authors:  Kim Timmermans; Matthijs Kox; Michiel Vaneker; Maarten van den Berg; Aaron John; Arjan van Laarhoven; Hans van der Hoeven; Gert Jan Scheffer; Peter Pickkers
Journal:  Intensive Care Med       Date:  2016-02-24       Impact factor: 17.440
  6 in total
  105 in total

1.  Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial.

Authors:  Eric J Lenze; Caline Mattar; Charles F Zorumski; Angela Stevens; Julie Schweiger; Ginger E Nicol; J Philip Miller; Lei Yang; Michael Yingling; Michael S Avidan; Angela M Reiersen
Journal:  JAMA       Date:  2020-12-08       Impact factor: 56.272

Review 2.  Severe Acute Respiratory Syndrome Coronavirus 2: Manifestations of Disease and Approaches to Treatment and Prevention in Humans.

Authors:  Michael E Watson; Kengo Inagaki; Jason B Weinberg
Journal:  Comp Med       Date:  2021-09-17       Impact factor: 0.982

3.  Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19.

Authors:  Alice G Vassiliou; Ioanna Dimopoulou; Edison Jahaj; Chrysi Keskinidou; Zafeiria Mastora; Stylianos E Orfanos; Anastasia Kotanidou
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

Review 4.  COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on "Two-Path Unifying Theory" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy.

Authors:  Jae C Chang
Journal:  Vasc Health Risk Manag       Date:  2021-06-01

5.  Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients.

Authors:  Esther J Nossent; Alex R Schuurman; Tom D Y Reijnders; Anno Saris; Ilse Jongerius; Siebe G Blok; Heder de Vries; JanWillem Duitman; Anton Vonk Noordegraaf; Lilian J Meijboom; René Lutter; Leo Heunks; Harm Jan Bogaard; Tom van der Poll
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

6.  IL-6 and Other Biomarkers associated with Poor Prognosis in a Cohort of Hospitalized Patients with COVID-19 in Madrid.

Authors:  Encarnación Donoso-Navarro; Ignacio Arribas Gómez; Francisco A Bernabeu-Andreu
Journal:  Biomark Insights       Date:  2021-05-24

Review 7.  Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19.

Authors:  Ivo Udovicic; Ivan Stanojevic; Dragan Djordjevic; Snjezana Zeba; Goran Rondovic; Tanja Abazovic; Srdjan Lazic; Danilo Vojvodic; Kendrick To; Dzihan Abazovic; Wasim Khan; Maja Surbatovic
Journal:  J Clin Med       Date:  2021-12-12       Impact factor: 4.241

8.  A digital protein microarray for COVID-19 cytokine storm monitoring.

Authors:  Yujing Song; Yuxuan Ye; Shiuan-Haur Su; Andrew Stephens; Tao Cai; Meng-Ting Chung; Meilan K Han; Michael W Newstead; Lenar Yessayan; David Frame; H David Humes; Benjamin H Singer; Katsuo Kurabayashi
Journal:  Lab Chip       Date:  2020-11-19       Impact factor: 6.799

9.  Extracorporeal Blood Purification in Moderate and Severe COVID-19 Patients: A Prospective Cohort Study.

Authors:  Rodney Alexander Rosalia; Petar Ugurov; Dashurie Neziri; Simona Despotovska; Emilija Kostoska; Lidija Veljanovska-Kiridjievska; Dimche Kuzmanov; Aleksandar Trifunovski; Dijana Popevski; Gianluca Villa; Zan Mitrev
Journal:  Blood Purif       Date:  2021-06-14       Impact factor: 2.614

10.  Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19.

Authors:  Ryan S Thwaites; Ashley Sanchez Sevilla Uruchurtu; Matthew K Siggins; Felicity Liew; Clark D Russell; Shona C Moore; Cameron Fairfield; Edwin Carter; Simon Abrams; Charlotte-Eve Short; Thilipan Thaventhiran; Emma Bergstrom; Zoe Gardener; Stephanie Ascough; Christopher Chiu; Annemarie B Docherty; David Hunt; Yanick J Crow; Tom Solomon; Graham P Taylor; Lance Turtle; Ewen M Harrison; Jake Dunning; Malcolm G Semple; J Kenneth Baillie; Peter Jm Openshaw
Journal:  Sci Immunol       Date:  2021-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.